We have focussed on oxycodone and hydrocodone as our initial products with codeine and morphine to follow quickly thereafter. Behind those products will be hydromorphone, oxymorphone, naltrexone, naloxone, nalbuphine,  nalmaphene, noscapine (narcotine), mepiridine, diphenoxylate, methadone, LAAM and buprenorphine. 

Of significance is that Penick already has completed the core process development efforts required for the manufacture of all of these APIs.